B
BDH Industries Ltd
BSE:524828
BDH Industries Ltd
BSE:524828
Price:
375.8
INR
-0.84%
Market Closed
Market Cap:
₹2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BDH Industries Ltd
BSE:524828
|
IN |
|
Sonendo Inc
OTC:SONX
|
US |
|
F
|
Flutter Entertainment PLC
F:PPB
|
IE |
|
Syngene International Ltd
NSE:SYNGENE
|
IN |
|
A
|
Artemis Hali AS
IST:ARTMS.E
|
TR |
|
Saab AB
STO:SAAB B
|
SE |
|
Bharat Gears Ltd
NSE:BHARATGEAR
|
IN |
|
Ihlas Yayin Holding AS
IST:IHYAY.E
|
TR |
|
Nihon Enterprise Co Ltd
TSE:4829
|
JP |
|
S4 Capital PLC
F:9S4
|
UK |
|
G
|
Golden Ventures Leasehold Real Estate Investment Trust
SET:GVREIT
|
TH |
|
GAM Holding AG
SIX:GAM
|
CH |
|
A
|
Ashapura Minechem Ltd
NSE:ASHAPURMIN
|
IN |
|
S
|
Solvay SA
XBER:SOL
|
BE |
|
M
|
Maggie Beer Holdings Ltd
ASX:MBH
|
AU |
|
Vestel Elektronik Sanayi ve Ticaret AS
IST:VESTL.E
|
TR |
|
Navigator Global Investments Ltd
ASX:NGI
|
AU |
Multiples-Based Value
The Multiples-Based Value of one BDH stock under the Base Case scenario is hidden INR. Compared to the current market price of 375.8 INR, BDH Industries Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BDH Multiples-Based Value
LOCKED
Multiples Across Competitors
BDH Competitors Multiples
BDH Industries Ltd Competitors
BDH Industries Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
B
|
BDH Industries Ltd
BSE:524828
|
2.2B INR | 2.6 | 20.8 | 14.1 | 15.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118B USD | 2.5 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
